M&A / Deals Sun Pharma to acquire Organon for $11.75bn Pharmaceutical TechnologySun Pharma has signed a definitive agreement to acquire Organon in a transaction with an enterprise valuation of $11.75bn in cash.Read full story pharminent April 27, 2026 (Last updated: April 27, 2026) Pharmaceutical Technology Sun Pharma has signed a definitive agreement to acquire Organon in a transaction with an enterprise valuation of $11.75bn in cash. Read full story Post navigation Previous: Sun sets out $11.75bn takeover play for OrganonNext: UK medicines regulator grants marketing authorisation to Enflonsia for RSV prevention Related Stories M&A / Deals Solstice Oncology secures $225m to drive porustobart’s development for cancer pharminent September 10, 2026 M&A / Deals UK’s Claret Capital raises 575m for European biotechs pharminent September 7, 2026 M&A / Deals GSK wagers up to $1.3B on a different kind of cancer drug pharminent September 3, 2026